Gemina Laboratories Ratios and Metrics

Market cap in millions CAD. Fiscal year is February - January.

Millions CAD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021
Market Capitalization	3	40	41	45	27	-
Market Cap Growth	-92.26%	-1.41%	-8.48%	63.35%	-	-
Enterprise Value	3	42	42	45	25	-
Last Close Price	0.04	0.54	0.56	0.70	0.50	-
PB Ratio	-0.60	-9.13	-25.90	-624.83	29.09	-
P/TBV Ratio	-	-	-	-	29.09	-
Debt / Equity Ratio	-0.05	-0.29	-0.31	-3.35	0.05	0.61
Net Debt / Equity Ratio	-0.05	-0.29	-0.31	-2.20	-1.18	-4.90
Net Debt / EBITDA Ratio	-0.08	-0.33	-0.09	-0.03	0.24	-
Net Debt / FCF Ratio	413.61	-0.98	-0.15	-0.03	0.29	1.84
Quick Ratio	0.00	0.01	0.01	0.27	2.86	0.39
Current Ratio	0.01	0.02	0.03	0.32	2.93	1.05
Return on Equity (ROE)	-	-	-	-1370.69%	-857.63%	-
Return on Assets (ROA)	-134.42%	-168.94%	-195.03%	-226.85%	-149.93%	-
Return on Capital Employed (ROCE)	55.20%	91.80%	376.80%	-4727.00%	-498.50%	-339.00%
Earnings Yield	-95.64%	-10.06%	-12.71%	-13.33%	-17.24%	-
FCF Yield	-	-3.21%	-8.00%	-10.23%	-14.13%	-
Buyback Yield / Dilution	-2.03%	-2.22%	-20.37%	-26.30%	-41.35%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.